comparemela.com

Latest Breaking News On - Edesa biotech inc - Page 5 : comparemela.com

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom
Toronto
Ontario
Canada
California
United-states
British
Gary-koppenjan
Edesa-biotech-inc
Nasdaq
British-columbia-securities-commission
Linkedin

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

California
United-states
United-kingdom
Toronto
Ontario
Canada
British
Nasdaq
Exchange-commission
News-network
British-columbia-securities-commission

Head to Head Review: Edesa Biotech (NASDAQ:EDSA) versus Lexaria Bioscience (NASDAQ:LEXX)

Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 31.3% of Edesa […]

Canada
Kelowna
British-columbia
Lexaria-bioscience
Lexaria-bioscience-corp
Edesa-biotech-inc
Yissum-research-development-company
Edesa-biotech
Get-free-report
Given-edesa-biotech
Edesa-biotech-daily
Nasdaq-edsa

Lexaria Bioscience (NASDAQ:LEXX) and Edesa Biotech (NASDAQ:EDSA) Head to Head Survey

Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Edesa Biotech (NASDAQ:EDSA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Volatility & Risk Lexaria Bioscience has a […]

Kelowna
British-columbia
Canada
Lexaria-bioscience
Lexaria-bioscience-corp
Edesa-biotech-inc
Yissum-research-development-company
Get-free-report
Edesa-biotech
Given-edesa-biotech
Lexaria-bioscience-daily
Nasdaq-lexx

Edesa Biotech Reports Fiscal Year 2023 Results

TORONTO, ON / ACCESSWIRE / December 15, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the fiscal year ended September 30, 2023 and provided an update on its b.

United-kingdom
San-francisco
California
United-states
Canada
Toronto
Ontario
British
Canadian
Stephen-lemieux
Gary-koppenjan
British-columbia-securities-commission

vimarsana © 2020. All Rights Reserved.